Two frequent polymorphisms of angiotensinogen and their association with multiple sclerosis progression rate

J Neurol Sci. 2011 Apr 15;303(1-2):31-4. doi: 10.1016/j.jns.2011.01.020. Epub 2011 Feb 12.

Abstract

A total of 195 patients with multiple sclerosis (MS) and 126 controls were investigated for angiotensinogen/(-6)A/G, M235T/and angiotensin converting enzyme I/D gene polymorphisms to test their association with MS susceptibility and/or disease progression using Global Multiple Sclerosis Severity Score (MSSS). We demonstrated a significant association of M235T polymorphism with MSSS. The MM homozygotes had the lowest (3.8), heterozygotes MT higher (5.2) and homozygotes TT the highest (5.4) mean MSSS values (P=0.02). For polymorphisms (-6)A/G of ATG, only a trend was observed (P=0.06), where the homozygotes GG carried lower MSSS values than heterozygotes and homozygotes AA. No significant association with susceptibility was observed. For ACE I/D polymorphism, neither significant differences in the genotype-phenotype study nor in the case-control study were observed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alleles
  • Angiotensinogen / blood
  • Angiotensinogen / genetics*
  • Case-Control Studies
  • Disease Progression
  • Female
  • Genetic Predisposition to Disease
  • Genetic Variation
  • Genotype
  • Heterozygote
  • Homozygote
  • Humans
  • Male
  • Multiple Sclerosis / genetics*
  • Multiple Sclerosis / pathology*
  • Peptidyl-Dipeptidase A / genetics
  • Polymorphism, Genetic
  • Renin-Angiotensin System / genetics

Substances

  • Angiotensinogen
  • Peptidyl-Dipeptidase A